Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-86974680 |
Trade Name | |
Synonyms | JNJ 86974680|JNJ86974680 |
Drug Descriptions |
JNJ-86974680 is an antagonist of the adenosine receptor A2AR (ADORA2A) expressed on T-lymphocytes, which may relieve adenosine-mediated immune suppression and enhance antitumor activity (NCI Drug Dictionary). |
DrugClasses | Adenosine Targeting 24 |
CAS Registry Number | NA |
NCIT ID | C202467 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetrelimab + JNJ-86974680 | Cetrelimab JNJ-86974680 | 0 | 1 |
JNJ-86974680 | JNJ-86974680 | 0 | 0 |